EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Volatilomic Signatures of Parental and Oxaliplatin-Resistant HCT116 Colon Cancer Cell Lines

Christine Heinzle, Andreas Leiherer iD, Axel Muendlein iD, Clemens Ager iD, Agnieszka Królicka iD, Chris A Mayhew, Pawel Mochalski

International Journal of Molecular Sciences · 13.07.2026 · 27 (14) · 6240

DOI: 10.3390/ijms27146240 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 13.07.2026. Verfasst von Christine Heinzle und 6 weiteren Autor:innen. Beteiligte Einrichtung: Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), 6800 Feldkirch, Austria. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Oxaliplatin, Volatile Organic Compounds, Colonic Neoplasms. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Volatile organic compounds (VOCs) reflect cellular metabolic activities and may serve as non-invasive biomarkers in oncology. This study investigated whether acquired oxaliplatin resistance in colorectal cancer is associated with distinct volatilomic alterations. The human colorectal cancer cell line HCT116 and its oxaliplatin-resistant derivative (OXrHCT116) were analyzed under basal conditions and following oxaliplatin exposure. Chemoresistance was confirmed using dose–response, cell viability, and colony formation assays. VOCs were analyzed by headspace needle trap extraction coupled with gas chromatography–mass spectrometry (HS-NTE-GC-MS). OXrHCT116 cells exhibited markedly reduced oxaliplatin sensitivity, increased IC50 values, and reduced proliferative and clonogenic capacity. Volatilomic profiling identified 55 significantly altered VOCs. Parental HCT116 cells displayed broader VOC diversity and higher turnover than OXrHCT116 cells. Hydrocarbons associated with lipid peroxidation and oxidative stress were more abundant in HCT116 cells, whereas resistant cells showed markedly reduced emission of these compounds. Additional alterations in aldehydes, alcohols, and aromatic compounds suggested reduced metabolic flux in resistant cells. Oxaliplatin exposure induced pronounced volatilomic changes in HCT116 cells but only minimal modulation in OXrHCT116 cells. These findings suggest that oxaliplatin resistance may be associated with distinct metabolic reprogramming and support VOC profiling as a promising approach for monitoring chemoresistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmOxaliplatinVolatile Organic CompoundsColonic NeoplasmsAntineoplastic AgentsOrganoplatinum CompoundsHumansHCT116 CellsGas Chromatography-Mass SpectrometryCell Survival

Stichwörter der Autor:innen

HS-NTE-GC-MScancer metabolismcolorectal canceroxaliplatin resistancevolatile organic compoundsvolatilomics

Substanzen

OxaliplatinVolatile Organic CompoundsAntineoplastic AgentsOrganoplatinum Compounds

Autor:innen und Institutionen

  • Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), 6800 Feldkirch, Austria.
  • Central Medical Laboratories, 6800 Feldkirch, Austria.
  • Faculty of Medical Sciences, Private University in the Principality of Liechtenstein, FL-9495 Triesen, Liechtenstein.
  • Institute for Breath Research, University of Innsbruck, 6020 Innsbruck, Austria.
  • Department of Building Materials Technology, Faculty of Materials Science and Ceramics, AGH University of Science and Technology, 30-059 Krakow, Poland.
  • Institute of Chemistry, Jan Kochanowski University, 25-369 Kielce, Poland.

ORCID-Profile: Andreas Leiherer, Axel Muendlein, Clemens Ager, Agnieszka Królicka

Zitieren

APA

Heinzle, C., Leiherer, A., Muendlein, A., Ager, C., Królicka, A., Mayhew, C. A., & Mochalski, P. (2026). Volatilomic Signatures of Parental and Oxaliplatin-Resistant HCT116 Colon Cancer Cell Lines. International Journal of Molecular Sciences, 27(14), 6240. https://doi.org/10.3390/ijms27146240

Vancouver

Heinzle C, Leiherer A, Muendlein A, Ager C, Królicka A, Mayhew CA, et al. Volatilomic Signatures of Parental and Oxaliplatin-Resistant HCT116 Colon Cancer Cell Lines. International Journal of Molecular Sciences. 2026;27(14):6240. doi:10.3390/ijms27146240

BibTeX
@article{Heinzle2026,
  author = {Heinzle, Christine and Leiherer, Andreas and Muendlein, Axel and Ager, Clemens and Królicka, Agnieszka and Mayhew, Chris A and Mochalski, Pawel},
  title = {Volatilomic Signatures of Parental and Oxaliplatin-Resistant HCT116 Colon Cancer Cell Lines},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {14},
  pages = {6240},
  doi = {10.3390/ijms27146240}
}
Kostenlos starten →